The use of LLMs in healthcare is still incredibly nascent, so many experts are calling for a safety framework to make this uncharted territory feel safer. There are still a lot of unknowns, but avoiding clinical use cases and not inputting patients’ health information seem to be the most important guardrails providers are putting around LLMs at the moment.
Data can help healthcare facilities improve patient safety, but first, healthcare leaders need to bring data from multiple sources together using a common taxonomy.
Travel nurses provide critical relief during staffing shortages and use of these professionals has increased in recent years. With this increase comes new and emerging risks. A review of closed malpractice claims data at Coverys reveals the top areas of vulnerability for travel nurses differs from other healthcare providers.
Nurses face challenges that put themselves and their patients at risk. Using closed claim data, Coverys identified nursing risk trends. A full report, including recommendations, will be released this year.
The report, Resilience in volatility: Modernizing the supply chain, highlights three areas that Fortune 500 and mid-size companies need to address to implement technology such as machine learning, cloud computing and risk management tools to improve production and delivery.
The report, Resilience in volatility: Modernizing the supply chain, highlights three areas that Fortune 500 and mid-size companies need to address to implement technology such as machine learning, cloud computing and risk management tools to improve production and delivery.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Despite best efforts and protection from federal and state immunity, you need to be prepared to defend Covid-19 related claims. Coverys offers guidance on how you can mitigate the impact.
Take a few moments to consider the importance of the documentation of your medical device company.
The FDA has arrived at your premises. What is your reaction? Are you ready? Here are some of the issues that we commonly see medical device companies trip over.
Coverys, which collects $420 million in malpractice premiums annually, has now completed five acquisitions in the last two years.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Medical device companies MUST have established risk management processes that comply with ISO 14971. And it doesn’t matter if you are developing medical devices in the U.S., EU, Canada, and so on. EVERY INTERNATIONAL REGULATORY AGENCY YOU’VE EVER HEARD OF ACCEPTS ISO 14971 AS THE RISK MANAGEMENT STANDARD FOR THE MEDICAL DEVICE INDUSTRY. ISO 14971 […]
It’s very clear from medical device regulatory bodies throughout the world that sound risk management processes are paramount for medical device companies.
If this story didn’t have a Bloomberg byline, I would swear it was from last night’s edition of The Daily Show. Hospitals are now buying consumer purchasing data to figure out who smokes, who has a car, and who shops at Walmart or Whole Foods. The idea is to identify high-risk patients and help them […]
Medical errors are part of medical practice. No matter how hard the healthcare system tries, no treatment will be free of risk. We need to accept that and start making better decisions.
Psilos is very proud of portfolio company SeeChange for being #20 on Fast Company's 2013 list of the world’s 50 companies whose innovations are having the greatest impacts across their industries and our culture as a whole.
